Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! AI is eating the world—and the machines behind it are ravenous. Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink. Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and b ...

Core Viewpoint - A class action securities lawsuit has been filed against C3.ai, Inc. due to alleged securities fraud impacting investors between February 26, 2025, and August 8, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit claims that C3.ai's management made misleading statements about the company's growth while concealing adverse facts, particularly regarding the health of its CEO, which affected the company's ability to close deals [2] - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and lowered its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health [2] - Following the announcement, C3.ai's stock price dropped from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of approximately 25.58% in just one day [2] Group 2: Next Steps for Investors - Investors who suffered losses in C3.ai during the specified timeframe have until October 21, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to allegations of misleading investors regarding its revenue outlook and growth potential, particularly related to CEO Thomas M. Siebel's health issues [3][4]. Group 1: Class Action Details - The class action lawsuit represents investors who purchased C3.ai securities between February 26, 2025, and August 8, 2025 [1]. - Investors have until October 21, 2025, to file a lead plaintiff motion [1]. Group 2: Allegations Against C3.ai - The lawsuit claims that C3.ai misled investors by presenting an overly optimistic revenue outlook while downplaying risks associated with the CEO's health [3]. - On August 8, 2025, C3.ai announced disappointing preliminary results for Q1 of fiscal year 2026 and lowered its full-year revenue guidance, attributing this to poor sales performance and CEO health concerns [4]. - Following this announcement, C3.ai's stock price dropped by more than 25% [4].

Core Points - The article highlights the upcoming deadline of October 21, 2025, for investors to file a lead plaintiff motion in a securities class action lawsuit related to C3.ai, Inc. [1] Company Summary - The lawsuit is on behalf of investors who purchased C3.ai, Inc. securities between February 26, 2025, and August 8, 2025, which is referred to as the "Class Period" [1]

Core Points - C3.ai, Inc. is facing a class action lawsuit due to allegations of providing misleading statements about its growth and the impact of its CEO's health on business operations [1][2] - The company announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to leadership reorganization and the CEO's health [1] - Following the announcement, C3.ai's stock price dropped approximately 25.58%, from $22.13 on August 8, 2025, to $16.47 on August 11, 2025 [1] Shareholder Information - Shareholders who purchased shares during the class period from February 26, 2025, to August 8, 2025, are encouraged to register for the class action and can do so without any cost or obligation [2] - The deadline for shareholders to seek lead plaintiff status is October 21, 2025 [2] Legal Representation - The Gross Law Firm is representing the shareholders and aims to protect investors' rights against deceit and fraud in business practices [3]

Core Insights - The information technology sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, with a value below 30 indicating potential buying opportunities [1] Company Summaries - **Accenture Plc (ACN)**: - Recently acquired IAMConcepts, a Canadian IAM services company - Stock has decreased approximately 26% over the past six months, with a 52-week low of $236.67 - Current RSI value is 28, and shares closed at $243.11 after a 3.5% drop [7] - **C3.ai Inc (AI)**: - Missed first-quarter earnings estimates and provided weak guidance - Stock fell around 5% in the past month, with a 52-week low of $14.70 - Current RSI value is 28, and shares closed at $15.61 after a 0.8% decline [7] - **Endava PLC (DAVA)**: - Reported mixed quarterly results, with a focus on AI integration in projects - Stock has decreased approximately 24% over the past month, with a 52-week low of $9.36 - Current RSI value is 25.7, and shares closed at $9.40 after a 5.3% drop [7]

Core Insights - The information technology sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, with a value below 30 indicating that a stock may be oversold [1] Company Summaries - **Accenture Plc (ACN)**: - Recently acquired IAMConcepts, a Canadian company specializing in identity and access management services - Stock has fallen approximately 26% over the past six months, with a 52-week low of $236.67 - Current RSI value is 28, and shares closed at $243.11 after a 3.5% decline [7] - **C3.ai Inc (AI)**: - Missed first-quarter earnings estimates and provided weak guidance - Stock has decreased around 5% over the past month, with a 52-week low of $14.70 - Current RSI value is 28, and shares closed at $15.61 after a 0.8% decline [7] - **Endava PLC (DAVA)**: - Reported mixed quarterly results, with a focus on AI integration among clients - Stock has dropped approximately 24% over the past month, with a 52-week low of $9.36 - Current RSI value is 25.7, and shares closed at $9.40 after a 5.3% decline [7]

Core Insights - C3.ai, Inc. has launched a new product called C3 AI Agentic Process Automation, which utilizes autonomous AI agents to manage business and operational workflows across enterprises [1][4] - The new product is designed to handle various business processes, including order-to-cash, customer service, invoice processing, debt collection, supplier onboarding, procurement, employee onboarding, industrial operations, manufacturing operations, production planning, inventory management, and aircraft maintenance [2] - By replacing traditional robotic process automation tools with AI models, the C3 AI Agentic Process Automation enhances enterprises' capabilities by integrating reasoning capabilities of modern AI with pre-determined steps and controls [3] Company Overview - C3.ai, Inc. is an enterprise artificial intelligence software company focused on building and operating enterprise-scale AI applications and facilitating digital transformation [4] - The CEO of C3 AI, Stephen Ehikian, emphasized that the C3 AI Agentic Process Automation represents a significant shift in the nature of work, enabling customers to efficiently manage complex workflows from start to finish [4]

Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its growth and the impact of its CEO's health on the company's performance [3][4]. Summary by Relevant Sections Allegations - The complaint claims that C3.ai's management provided overly positive statements while concealing material adverse facts about the company's growth, particularly the CEO's health affecting deal closures [3]. - The company announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health [3]. Stock Price Impact - Following the announcement on August 8, 2025, C3.ai's stock price dropped from $22.13 per share to $16.47 per share by August 11, 2025, marking a decline of approximately 25.58% in just one day [3]. Class Action Details - Shareholders who purchased shares during the class period from February 26, 2025, to August 8, 2025, are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for October 21, 2025 [4]. - Participants will be enrolled in a portfolio monitoring system to receive updates throughout the case [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5].

Core Insights - C3.ai, Inc. has experienced a significant decline in stock price, dropping 36.2% over the past three months, compared to an 8.5% decline in the industry and a 9% increase in the S&P 500 [1][5][6] - The company's shares closed at $15.74, just above its 52-week low of $14.70, indicating a challenging market position [1][5] - C3.ai's recent quarterly performance revealed a nearly 20% year-over-year revenue decline, with sales missing expectations and widening losses at both operating and net levels [5][9] Financial Performance - The company reported a gross margin of 52%, which is below investor expectations, and has withdrawn its full-year guidance, indicating management's uncertainty about future performance [6][8][9] - The Zacks Consensus Estimate for fiscal 2026 and 2027 loss per share has widened, with current estimates showing a loss of $1.37 for the current year and $0.60 for the next year [14][15] - The estimated sales for fiscal 2026 imply a year-over-year decline of 5.6%, while growth of 15.2% is expected for fiscal 2027 [15] Operational Challenges - Poor sales execution has been identified as a major factor behind the weak quarterly performance, exacerbated by leadership changes and restructuring within the sales and service teams [6][9] - The company has relied heavily on initial production deployments, which have higher upfront costs and limited immediate revenues, negatively impacting scale efficiencies [7][9] - Leadership transitions, including the founder stepping back and a new CEO being appointed, introduce additional risks during a critical period of execution challenges [9] Market Opportunities - Despite recent challenges, C3.ai highlights strong long-term opportunities, including an expanding customer base across various industries such as manufacturing and defense [10][11] - The company has secured partnerships with large enterprises, indicating ongoing demand for its technology [10][11] - C3.ai's extensive product portfolio and new Strategic Integrator Program position it to capture a larger share of the estimated $2 trillion addressable market in enterprise AI [13] Valuation - C3.ai is currently priced at a discount relative to its industry, with a forward 12-month price-to-sales ratio of 5.46, significantly lower than peers like Palantir Technologies and Snowflake [16]